Navigation Links
A Recent Study by ITG's Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
Date:6/1/2011

NEW YORK, June 1, 2011 /PRNewswire/ -- A study published this week by ITG's Majestic Market Research revealed that Novartis' recently approved drug, Gilenya, continues to steal share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year.  Gilenya came onto the market in late September 2010 as the first FDA-approved oral disease-modifying MS drug.  Despite negative sentiment around Gilenya's lengthy initiation process, neurologists are embracing the new drug at an impressive rate.  Real time data from ITG's proprietary physician panel indicate that Gilenya was the disease-modifying treatment of choice for 20% of new written MS prescriptions in April.  Furthermore, surveyed neurologists indicated that their prescribing of Gilenya will increase significantly over the course of 2011 as they continue to shift inadequate responders from other MS therapies to the new drug.

The study takes an in-depth look at how Gilenya's multi-step initiation process is impacting neurologists' use of the drug.  According to neurologists, new treatment starts for Gilenya typically take between three to six weeks and involve the scheduling and organization of prescreening tests and ongoing monitoring for adverse events.  

Physicians reported that Novartis plays an important role in facilitating these steps. In fact, 63% of Gilenya prescribers indicated that they receive support from Novartis during this process, and 25% of them classified this assistance as superior to what competing companies offer for their products.  

By comparison, neurologists appear unable to get over similar concerns about Acorda Therapeutics' Ampyra, which was launched in March 2010 as the first FDA approved drug to improve walking in MS patients. Like Gilenya, Ampyra is associated with an onerous initi
'/>"/>

SOURCE ITG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
4. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
5. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
6. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
11. Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29 luglio 2015 Uno studio clinico ... l,ingestione quotidiana del probiotico L. reuteri di ... modifica la produzione intestinale di fattori proteici che ... somministrazione quotidiana di ceppo di L. reuteri ... utilizzando il sistema di somministrazione brevettato BIO- tract ...
(Date:7/29/2015)... , July 29, 2015  Cryoport, Inc. ... "Company"), the leading provider of advanced cryogenic ... serving markets including immunotherapies, stem cells, cell ... health, and reproductive medicine, announced today that ... common stock and warrants (the "Units") under a registered ...
(Date:7/29/2015)... Heska Corporation (NASDAQ: HSKA - News; ... diagnostic and other specialty veterinary products , today reported financial ... Second Quarter 2015 Highlights with Prior Year Comparison: ... $1.829 million, from $917 thousand. , Blood Analyzer and ... , Core Companion Animal revenue was up 19% to ...
Breaking Medicine Technology:È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8
... Hospital – one of the region,s leaders in minimally ... removal in the Washington and Oregon region on March ... Evergreen,s Dr. Michael Towbin removed the gallbladders ... 33-year-old woman – making a small, single incision in ...
... March 30, 2012  The launch landscape for new pharmaceutical ... influence two of the biggest changes facing launch teams. ... products has never been greater with the pharmaceutical industry ... In this challenging new launch environment, Best ...
Cached Medicine Technology:Evergreen Hospital Performs Region's First Single-Site Gallbladder Removal Using da Vinci Robot 2Evergreen Hospital Performs Region's First Single-Site Gallbladder Removal Using da Vinci Robot 3Excellence Services Program Helps Guide Pharmaceutical Industry Through the New Product Launch Landscape 2
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has ... U.S. Health division. In her position, Ramkeesoon will help build and expand ... Abt, Ramkeesoon spent close to a decade at ICF International, most recently as ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... According ... states where marijuana is legal, and are exposed to advertisements, for medicinal use are ... revealed teenagers in settings where the use of marijuana is considered beneficial are more ...
(Date:7/29/2015)... ... July 29, 2015 , ... The report “Atherosclerosis ... Atherosclerosis. Atherosclerosis is a slow, progressive disease that may start in childhood. The ... and best-in-class products. Complete report on Atherosclerosis Pipeline with 78 market data tables ...
(Date:7/29/2015)... NJ (PRWEB) , ... July 29, 2015 , ... ... (the Commission) CCM® credential for a five-year period, expiring November 30, 2019, during ... CCM credential by submitting an application demonstrating the program’s compliance with the NCCA’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit ... name in July to Kalamazoo Strength & Conditioning. , The name change coincides ... the evolution of our training center over the past three years,” according to ...
Breaking Medicine News(10 mins):Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4
... on results of a landmark study, researchers at Mayo Clinic,s ... eliminate the need to remove colon polyps that are not ... Currently one-third to one-half of the polyps removed during colonoscopies ... by pathologists, and this increases time, expense and the potential ...
... comes at stem cell symposium, ANN ARBOR, Mich., ... A. Alfred Taubman announced a $22 million gift to ... aimed at,understanding, treating and preventing human disease., Today, ... --,announcing that he will bequeath an additional $22 million ...
... University of Utah researchers have developed a magnetic resonance imaging ... of the heart,s left atrium in patients who have undergone ... study are published in the Oct. 7, 2008, issue of ... , Atrial fibrillation (AF) is an arrhythmia, or abnormal ...
... The Catholic Health,Association of the United States (CHA) ... Covenant Health Systems, Lexington, MA;,and Trinity Health, Novi, ... awareness about global climate change., Through receipt ... for the Environment (NRPE) and the Catholic Coalition ...
... Majesco Entertainment,Company (Nasdaq: COOL ), an innovative provider ... Jillian Michaels, Fitness Ultimatum 2009 has,gone gold and is ... game is,the first of its kind to integrate a ... life coach on the popular television,series "The Biggest Loser" ...
... Medical Devices Inc.,(CleveMed) announced it has been ... from the National Institute on Aging to ... in deep brain,stimulation (DBS) procedures for Parkinson,s ... the Center for Neurological Restoration of,the Cleveland ...
Cached Medicine News:Health News:Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half 2Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Novel imaging approach may assist in predicting success of treatment for atrial fibrillation 2Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 3Health News:CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinson's Disease 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: